Qube Research & Technologies (QRT)
AGL icon

Qube Research & Technologies (QRT)’s Agilon Health AGL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,290
Closed -$4.31M – 3734
2024
Q1 		$4.31M Buy
28,290
+27,532
+3,632% +$4.58M 0.01% 1321
2023
Q4 		$238K Buy
+758
New +$274K ﹤0.01% 2702
2021
Q4 		– Sell
-1,840
Closed -$1.21M – 2481
2021
Q3 		$1.21M Buy
1,840
+1,642
+829% +$1.4M 0.02% 841
2021
Q2 		$201K Buy
+198
New +$173K ﹤0.01% 1796

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AGL Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 28,290 shares — an estimated $4.31M sold.

Qube Research & Technologies (QRT) first reported a position in AGL in Q2 2021 and held it in 4 quarters. The position peaked at $4.31M in Q1 2024. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 28,290 Agilon Health shares in Q2 2024, an estimated $4.31M.
  • Qube Research & Technologies (QRT) first reported a position in Agilon Health in Q2 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Agilon Health position peaked at $4.31M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.